1. Home
  2. CRSP vs MHK Comparison

CRSP vs MHK Comparison

Compare CRSP & MHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$50.21

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Logo Mohawk Industries Inc.

MHK

Mohawk Industries Inc.

HOLD

Current Price

$102.41

Market Cap

5.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSP
MHK
Founded
2013
1988
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.9B
IPO Year
2016
1995

Fundamental Metrics

Financial Performance
Metric
CRSP
MHK
Price
$50.21
$102.41
Analyst Decision
Buy
Buy
Analyst Count
17
11
Target Price
$70.29
$126.10
AVG Volume (30 Days)
1.7M
950.3K
Earning Date
05-11-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.90
Revenue
$289,590,000.00
N/A
Revenue This Year
$807.72
$3.38
Revenue Next Year
$172.52
$3.09
P/E Ratio
N/A
$53.75
Revenue Growth
9169.85
N/A
52 Week Low
$35.38
$92.99
52 Week High
$78.48
$143.13

Technical Indicators

Market Signals
Indicator
CRSP
MHK
Relative Strength Index (RSI) 46.50 51.74
Support Level $44.82 $94.44
Resistance Level $60.45 $107.39
Average True Range (ATR) 2.49 3.76
MACD -0.37 0.30
Stochastic Oscillator 35.44 66.06

Price Performance

Historical Comparison
CRSP
MHK

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About MHK Mohawk Industries Inc.

Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Global Ceramic designs, manufactures, sources, distributes and markets a broad line of ceramic, porcelain and natural stone tile products used for floor and wall applications in residential and commercial channels for both remodeling and new construction. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.

Share on Social Networks: